Apoptosis as a Determinant of Atherothrombosis

Summary Clinical manifestations of atherosclerosis are the consequences of atherosclerotic plaque rupture that triggers thrombus formation. Tissue factor (TF) is a key element in the initiation of the coagulation cascade and is crucial in thrombus formation following plaque disruption. TF activity is highly dependent on the presence of phosphatidylserine (PS), an anionic phospholipid that is redistributed on the cell surface during apoptotic death conferring a potent procoagulant activity to the apoptotic cell. Apoptosis occurs in the human atherosclerotic plaque and shed membrane apoptotic microparticles rich in PS are produced in considerable amounts within the lipid core. These microparticles carry almost all TF activity and are responsible for the procoagulant activity of the plaque. Moreover, luminal endothelial cell apoptosis might be responsible for thrombus formation on eroded plaques without rupture. Apoptosis might also play a major role in blood thrombogenicity via circulating procoagulant microparticles that are found at high levels in patients with acute coronary syndromes.

[1]  R. Virmani,et al.  Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. , 2000, The American journal of pathology.

[2]  D. Girelli,et al.  Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. , 2000, The New England journal of medicine.

[3]  A. Tedgui,et al.  Apoptosis in the vasculature: mechanisms and functional importance , 2000, British journal of pharmacology.

[4]  O. Tricot,et al.  Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. , 2000, Circulation.

[5]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[6]  J. Freyssinet,et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.

[7]  R. Virmani,et al.  Plaque Rupture and Plaque Erosion , 1999, Thrombosis and Haemostasis.

[8]  M. Mesri,et al.  Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[9]  G. Grau,et al.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.

[10]  Zahi A Fayad,et al.  Acute coronary syndromes: biology , 1999, The Lancet.

[11]  E. Dennis,et al.  Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  V. Fuster,et al.  Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. , 1999, Circulation.

[13]  Y. Hannun,et al.  Inhibition of Caspases Inhibits the Release of Apoptotic Bodies: Bcl-2 Inhibits the Initiation of Formation of Apoptotic Bodies in Chemotherapeutic Agent-induced Apoptosis , 1999, The Journal of cell biology.

[14]  R. Virmani,et al.  Plaque rupture and sudden death related to exertion in men with coronary artery disease. , 1999, JAMA.

[15]  J. Badimón,et al.  Blood-borne tissue factor: another view of thrombosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Tedgui,et al.  Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[17]  J. Freyssinet,et al.  Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. , 1999, Circulation.

[18]  A. Zeiher,et al.  Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? , 1999, European cytokine network.

[19]  D. Isenberg,et al.  Apoptosis and antiphospholipid antibodies. , 1998, Seminars in arthritis and rheumatism.

[20]  L. Obeid,et al.  Regulation of membrane release in apoptosis. , 1998, The Biochemical journal.

[21]  B. Lüderitz,et al.  Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[22]  W. Jacob,et al.  Apoptosis and related proteins in different stages of human atherosclerotic plaques. , 1998, Circulation.

[23]  S. Izumo,et al.  Apoptosis: basic mechanisms and implications for cardiovascular disease. , 1998, Circulation research.

[24]  J. Piette,et al.  The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. , 1998, The Journal of clinical investigation.

[25]  Jennifer L Hall,et al.  Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease , 1998, Nature Medicine.

[26]  P. Maurer,et al.  Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67. , 1997, Circulation.

[27]  T. Littlewood,et al.  Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. , 1997, Circulation research.

[28]  P. Libby,et al.  The unstable atheroma. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[29]  A. Tedgui,et al.  Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. , 1997, Circulation.

[30]  M J Davies,et al.  Relation of plaque lipid composition and morphology to the stability of human aortic plaques. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[31]  M. Bennett,et al.  Thrombin generation by apoptotic vascular smooth muscle cells. , 1997, Blood.

[32]  W. Schaper,et al.  The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. , 1997, Atherosclerosis.

[33]  R. Virmani,et al.  Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. , 1997, The New England journal of medicine.

[34]  J. Freyssinet,et al.  The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. , 1997, The Journal of clinical investigation.

[35]  J. Thyberg,et al.  Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. , 1997, Atherosclerosis.

[36]  E. Bramucci,et al.  Tissue-factor antigen and activity in human coronary atherosclerotic plaques , 1997, The Lancet.

[37]  A. Schroit,et al.  Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. , 1997, Blood.

[38]  V. Fuster,et al.  Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. , 1997, Circulation.

[39]  Samin K. Sharma,et al.  Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. , 1996, Circulation.

[40]  J. Skepper,et al.  FOAM CELL APOPTOSIS AND THE DEVELOPMENT OF THE LIPID CORE OF HUMAN ATHEROSCLEROSIS , 1996, The Journal of pathology.

[41]  Samin K. Sharma,et al.  Identification of active tissue factor in human coronary atheroma. , 1996, Circulation.

[42]  B. Björkerud,et al.  Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. , 1996, The American journal of pathology.

[43]  F J Schoen,et al.  Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[44]  R. Virmani,et al.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. , 1996, Circulation.

[45]  David W. Banner,et al.  The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.

[46]  M. Petri,et al.  Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Bultinck,et al.  Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. , 1996, Atherosclerosis.

[48]  D. Green,et al.  Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.

[49]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[50]  P. Libby,et al.  Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.

[51]  M. Leon,et al.  Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.

[52]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[53]  J. Isner,et al.  Apoptosis in human atherosclerosis and restenosis. , 1995, Circulation.

[54]  G. Evan,et al.  Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. , 1995, The Journal of clinical investigation.

[55]  L. Sarda,et al.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells , 1995, Cell.

[56]  R. Kornbluth.  The immunological potential of apoptotic debris produced by tumor cells and during HIV infection. , 1994, Immunology letters.

[57]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[58]  V. Fuster,et al.  Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. , 1994, Circulation.

[59]  J. Freyssinet,et al.  Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. , 1994, Journal of immunology.

[60]  V. Fuster,et al.  Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.

[61]  V. Fuster,et al.  Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. , 1994, Journal of the American College of Cardiology.

[62]  G. Evan,et al.  Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. , 1994, Circulation research.

[63]  R D Kamm,et al.  Mechanical properties of model atherosclerotic lesion lipid pools. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[64]  B. Lentz,et al.  Specific contribution of different phospholipid surfaces to the activation of prothrombin by the fully assembled prothrombinase. , 1993, The Journal of biological chemistry.

[65]  C. Haslett,et al.  Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. , 1992, Journal of immunology.

[66]  R D Kamm,et al.  Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. , 1992, Circulation research.

[67]  A. Barger,et al.  Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction. , 1990, The American journal of cardiology.

[68]  D. Rifkin,et al.  Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[69]  P. Constantinides,et al.  Electron Microscopic Exploration of Human Endothelium in Step‐Serial Sections of Early and Advanced Atherosclerotic Lesions , 1990, Annals of the New York Academy of Sciences.

[70]  S. Schwartz,et al.  Cell proliferation in human coronary arteries. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[71]  V. Fuster,et al.  Angiographic progression of coronary artery disease and the development of myocardial infarction. , 1988, Journal of the American College of Cardiology.

[72]  A. Barger,et al.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.

[73]  J. M. Reiner,et al.  Population dynamics of arterial smooth muscle cells. V. Cell proliferation and cell death during initial 3 months in atherosclerotic lesions induced in swine by hypercholesterolemic diet and intimal trauma. , 1976, Experimental and molecular pathology.

[74]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[75]  W. Cliff.  The aortic tunica media in aging rats. , 1970, Experimental and molecular pathology.

[76]  R. Virchow,et al.  Cellular Pathology, as Based upon Physiological and Pathological Histology , 1860, Nutrition reviews.

[77]  K. Rentrop.  Thrombi in acute coronary syndromes : revisited and revised. , 2000, Circulation.

[78]  A. Blann,et al.  HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Direct Evidence of Endothelial Injury in Acute Myocardial Infarction and Unstable Angina by Demonstration of Circulating Endothelial Cells , 1999 .

[79]  J. Freyssinet,et al.  Oxysterols induce membrane procoagulant activity in monocytic THP-1 cells , 1998 .

[80]  A. Karsan,et al.  Apoptotic vascular endothelial cells become procoagulant. , 1997, Blood.

[81]  P. Libby,et al.  Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[82]  K. Channon,et al.  Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. , 1995, Circulation.

[83]  H. Weiss.  Scott syndrome: a disorder of platelet coagulant activity. , 1994, Seminars in hematology.

[84]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.